Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study

DE Bonds, JC Larson, AV Schwartz… - The Journal of …, 2006 - academic.oup.com
Context: Some but not all studies have shown higher rates of fracture in individuals with type
2 diabetes. Objective: The objective of the study was to determine the risk of fracture in …

Mortality and cardiac and vascular outcomes in extremely obese women

K McTigue, JC Larson, A Valoski, G Burke, J Kotchen… - Jama, 2006 - jamanetwork.com
ContextObesity, typically measured as body mass index of 30 or higher, has 3 subclasses:
obesity 1 (30-34.9); obesity 2 (35-39.9); and extreme obesity (≥ 40). Extreme obesity is …

Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative

IH De Boer, LF Tinker, S Connelly, JD Curb… - Diabetes …, 2008 - Am Diabetes Assoc
OBJECTIVE—Experimental and epidemiologic studies suggest that calcium and vitamin D
may reduce the risk of developing diabetes. We examined the effect of calcium plus vitamin …

Effect of estrogen therapy on gallbladder disease

DJ Cirillo, RB Wallace, RJ Rodabough, P Greenland… - Jama, 2005 - jamanetwork.com
ContextEstrogen therapy is thought to promote gallstone formation and cholecystitis but
most data derive from observational studies rather than randomized trials. ObjectiveTo …

Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study

BV Howard, L Kuller, R Langer, JAE Manson, C Allen… - Circulation, 2005 - Am Heart Assoc
Background—Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in
women and may vary by hysterectomy (or oophorectomy) status. This study compared CVD …

Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial

EW Freeman, KA Guthrie, B Caan, B Sternfeld… - Jama, 2011 - jamanetwork.com
Context Concerns regarding the risks associated with estrogen and progesterone to
manage menopausal symptoms have resulted in its declining use and increased interest in …

Symptom experience after discontinuing use of estrogen plus progestin

JK Ockene, DH Barad, BB Cochrane, JC Larson… - Jama, 2005 - jamanetwork.com
ContextLittle is known about women's experiences after stopping menopausal hormone
therapy. ObjectiveTo describe women's symptoms and management strategies after …

Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative

PM Rautaharju, C Kooperberg, JC Larson, A LaCroix - Circulation, 2006 - Am Heart Assoc
Background—Information is limited about the independent prognostic value of repolarization
abnormalities in women. Methods and Results—We evaluated hazard ratios for ECG …

Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial

CM Mitchell, SD Reed, S Diem, JC Larson… - JAMA internal …, 2018 - jamanetwork.com
Importance Nearly half of postmenopausal women report bothersome vulvovaginal
symptoms, but few data support the efficacy of 2 commonly recommended treatments …

Sleep duration and risk of ischemic stroke in postmenopausal women

JC Chen, RL Brunner, H Ren, S Wassertheil-Smoller… - Stroke, 2008 - Am Heart Assoc
Background and Purpose—Many studies have shown a U-shape association between sleep
duration and mortality, but epidemiological evidence linking cardiovascular diseases with …